Abstract
Spatial and temporal control of proteome expression is critical for cellular homeostasis. The ability to regulate polypeptide synthesis allows the cell to rapidly respond to changes in its environment. Under stress conditions, capdependent translation initiation is downregulated and alternative mechanisms of translation initiation are favoured for the production of critical proteins that ultimately determine whether the cell is able to overcome the stress. One such alternative mechanism of translation initiation is mediated by sequence elements located downstream of the 5 cap structure that are able to directly recruit ribosomes to a region proximal to the translation start site. Identifying the eukaryotic mRNAs that contain such internal ribosome entry sites (IRESes) is an important first step in cataloguing the cellular complement of proteins whose expression is translationally regulated during cellular stress and understanding how cells regulate translation under stress conditions. To date, no consensus sequence motif or structure has been identified as a signature of cellular IRES activity, making it difficult to identify the full complement of eukaryotic IRESes. This review will underscore the challenges faced in identifying IRESes on a genomic scale and potential solutions will be presented.
Keywords: IRES, translation, stress, differentiation, microarray, polysome
Current Genomics
Title: An Approach to Whole-Genome Identification of IRES Elements
Volume: 7 Issue: 4
Author(s): Tyson E. Graber, Stephen M. Lewis and Martin Holcik
Affiliation:
Keywords: IRES, translation, stress, differentiation, microarray, polysome
Abstract: Spatial and temporal control of proteome expression is critical for cellular homeostasis. The ability to regulate polypeptide synthesis allows the cell to rapidly respond to changes in its environment. Under stress conditions, capdependent translation initiation is downregulated and alternative mechanisms of translation initiation are favoured for the production of critical proteins that ultimately determine whether the cell is able to overcome the stress. One such alternative mechanism of translation initiation is mediated by sequence elements located downstream of the 5 cap structure that are able to directly recruit ribosomes to a region proximal to the translation start site. Identifying the eukaryotic mRNAs that contain such internal ribosome entry sites (IRESes) is an important first step in cataloguing the cellular complement of proteins whose expression is translationally regulated during cellular stress and understanding how cells regulate translation under stress conditions. To date, no consensus sequence motif or structure has been identified as a signature of cellular IRES activity, making it difficult to identify the full complement of eukaryotic IRESes. This review will underscore the challenges faced in identifying IRESes on a genomic scale and potential solutions will be presented.
Export Options
About this article
Cite this article as:
Graber E. Tyson, Lewis M. Stephen and Holcik Martin, An Approach to Whole-Genome Identification of IRES Elements, Current Genomics 2006; 7 (4) . https://dx.doi.org/10.2174/138920206778426988
DOI https://dx.doi.org/10.2174/138920206778426988 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Developments on Endothelin Antagonists as Immunomodulatory Drugs - from Infection to Transplantation Medicine
Recent Patents on Cardiovascular Drug Discovery Exploiting Anti-Inflammation Effects of Flavonoids in Chronic Inflammatory Diseases
Current Pharmaceutical Design Autologous Fat Transfer and Cell-Based Strategies for Soft Tissue Reconstruction
Current Tissue Engineering (Discontinued) Management of Blood Pressure and Heart Rate in Patients with Acute Stroke
Current Pharmaceutical Design Modeling Loss of Microvascular Wall Homeostasis during Glycocalyx Deterioration and Hypertension that Impacts Plasma Filtration and Solute Exchange
Current Neurovascular Research Mitochondrial Aldehyde Dehydrogenase, A Potential Drug Target for Protection of Heart and Brain from Ischemia/Reperfusion Injury
Current Drug Targets Edaravone (3-Methyl-1-Phenyl-2-Pyrazolin-5-one), A Novel Free Radical Scavenger, for Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Induced Pluripotent Stem Cells (iPSCs) Derived from Different Cell Sources and their Potential for Regenerative and Personalized Medicine
Current Molecular Medicine Human Mesenchymal Stem Cells Increases Expression of α-Tubulin and Angiopoietin 1 and 2 in Focal Cerebral Ischemia and Reperfusion
Current Neurovascular Research Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications
Current Vascular Pharmacology Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation
Current Drug Targets Remote Preconditioning- Endocrine Factors in Organ Protection Against Ischemic Injury
Endocrine, Metabolic & Immune Disorders - Drug Targets Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?
Current Cardiology Reviews Differentiation Potential of Mesenchymal Stem Cells Derived from Adipose Tissue vs Bone Marrow Toward Annulus Fibrosus Cells In vitro
Current Stem Cell Research & Therapy Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’
Current Pharmaceutical Design Metabolic Syndrome and Myocardial Infarction in Women
Current Pharmaceutical Design Adrenomedullin in Cardiovascular Disease: A Useful Biomarker, its Pathological Roles and Therapeutic Application
Current Protein & Peptide Science Neuregulin1 as Novel Therapy for Heart Failure
Current Pharmaceutical Design B-Type Natriuretic Peptide for Diagnosis and Therapy
Recent Patents on Cardiovascular Drug Discovery